AzTrials
AzTrials

Post COVID ConditionNCT06689345

Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19

A study testing taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation and rTMS - repetitive transcranial magnetic stimulation in people with Post COVID Condition and Chronic Pain, run by Federal University of ABC at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Read more about this study

Who is it for?
Ages 18 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Post COVID Condition, Chronic Pain, Healthy
What is being tested?
taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation and rTMS - repetitive transcranial magnetic stimulation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
55 participants
Where
1 siteBrazil
Study dates
21 Apr 2024to 16 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy individuals, both sexes, aged between 18 and 40 years (first arm).
  • Diagnosis of primary chronic pain (for more than 3 months), such as fibromyalgia (chronic widespread pain), primary chronic headache and orofacial pain, chronic primary visceral pain, post-COVID pain, and chronic primary musculoskeletal pain;
  • In the case of post-COVID-19 pain, the symptoms must be present for at least 12 weeks. The complaints of pain, fatigue, and/or changes in mental health should have started after infection by SARS-Cov-2.

Who cannot join

  • Individuals who present dysautonomia;
  • obese individuals with a high abdominal fat index characterized by a waist/hip ratio of 0.80 for women and 0.95 for men;
  • heart disease;
  • diabetes mellitus;
  • vestibular alterations characterized by the Dix-Hallpike maneuver, supine rotation test, arc test, side-lying maneuver, and post-head-shake nystagmus;
  • diagnosis of epilepsy or first-degree family history of epilepsy
Show all 14Show fewer
  • fever;
  • chronic consumption of alcohol, or other recreational drugs;
  • presence of contraindications for the use of non-invasive neuromodulation;
  • those who become ill with COVID-19 during the data collection period;
  • those who are unable to answer the evaluation questionnaires;
  • those with clinical instability;
  • those who have a previous history of chronic pain or fatigue before contracting COVID-19;
  • those who have neuropathic pain.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Federal University of ABC

    Sâo Bernardo Do Campo, São Paulo, 09606045

Other trials in Brazil

About this study

Official title: Effects of Non-invasive Neuromodulation on Post-COVID-19 Syndrome: Multicenter Study

The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Several studies have shown that many people with primary chronic pain and also people who have had COVID patients continue to have pain and fatigue that may be due to changes that occur in the brain and the vagus nerve that passes through the neck might cause inflammation. Therefore the aim of this study is to investigate if these electrical stimulations can help improve the condition of the brain and nerve and consequently, the inflammation so that these complaints improve.

This study will be organized as the following: It will begin with an assessment, divided into a part with questionnaires and another with specific tests. The questionnaires are aimed at understanding volunteer's characteristics, pain, fatigue, inflammation, sleep, quality of life, and the presence of symptoms of anxiety and depression. Next, the volunteer will undergo two tests to assess the behavior of his/her brain. They are performed using EEG electroencephalography and transcranial magnetic stimulation (TMS).

Read more
  • Quantitative EEG at rest - In this technique, a cap with electrodes is placed on volunteer's head, in contact with hair, which are connected through a gel. The volunteer needs to remain still for 6 minutes with eyes closed, sitting in a comfortable chair.
  • TMS with EEG - First, the volunteer will be asked to honestly answer the questions in the safety questionnaire for using this technique. Honest answers will eliminate the risks associated with this evaluation. Next, the volunteer's skin will be cleaned with alcohol and a special paste and place three self-adhesive electrodes on the muscle of the volunteer's hand, in a muscle called the interosseous, on the side where he/she writes. These electrodes will only capture the electrical activity of the muscle. Next, a series of magnetic pulses will be administered to the volunteer's skull, in the area that controls the hand muscle. It will contract with each pulse and, with this, so that the functioning of this connection can be understood. At the same time, the EEG device will capture the brain activities that occur during this TMS stimulation. During this exam, the volunteer may feel anything from no stimulation to muscle contractions that move his/her hand. Some people also experience redness under the electrodes, fatigue, or muscle/joint pain.

After the assessments, volunteers will be randomly selected to receive neuromodulation sessions using low-intensity electrical stimulation of the vagus nerve, using electrodes in the outer ear (active group), or sessions that only simulate this neuromodulation (sham, or placebo, group). This will occur for five consecutive days, starting on the day of the assessment. This stimulation is very weak and may not even be felt by the person receiving it. This technique is safe and the most that may occur is redness or itching of the skin. A few people may also experience tingling, a burning sensation or momentary local pain, fatigue, drowsiness, difficulty concentrating and a feeling of nervousness during or after the stimulation.

At the end of the 5 days of electrical stimulation, the same initial assessments will be repeated to see if anything has changed in the volunteer's brain, heart rate, blood pressure, pain, fatigue, inflammation, sleep, quality of life, depression, and anxiety.

Being tested
taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation, rTMS - repetitive transcranial magnetic stimulation, taVNS sham
Keywords
neuromodulation, chronic pain, covid-19, TMS-EEG, vagal nerve
Medical subject headings
Post-Acute COVID-19 Syndrome, Chronic Pain, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • taVNS - transauricular vagal nerve stimulationDevice

    30 minutes of electrical stimulation on the afferent portion of the vagal nerve on the cymba conchae of the ear, in the following configuration: 30 seg ramp up, 30 seg on, 30 seg off in intensity on which the volunteer feels a light tingling.

  • rPMS - repetitive peripheric magnetic stimulationDevice

    Magnetic stimulation on the efferent portion of the vagal nerve on the neck, on the following configuration: 20Hz, 25 pulses in the trein, in every inhalation, for 20 inhalations with 50% of machine capacity (500 pulses total).

  • rTMS - repetitive transcranial magnetic stimulationDevice

    rTMS intermitent theta- burst on the left DLPFC, on the following configuration: 50 Hz in treins of 5Hz, with 110% of the resting motor limiar and 600 pulses in 3 minutes.

  • taVNS shamDevice

    Simulated taVNS (SHAM) on helix left ear, that is the same as taVNS, but during only 1 minute

Study groups in NCT06689345
Study groupRoleWhat they receive
Healthy subjectsOtherOnce a week, each subject will receive a random stimulation in one of the following areas: (i) the afferent portion of the vagal nerve on the Cymba Conchae of the left ear (taVNS); (ii) rPMS on an efferent portion of the vagal nerve on the neck; (iii) rTMS intermittent theta- burst on the left DLPFC; (iv) simulated taVNS (SHAM) on helix left ear or.
Receives: Device: taVNS - transauricular vagal nerve stimulation; Device: rPMS - repetitive peripheric magnetic stimulation; Device: rTMS - repetitive transcranial magnetic stimulation; Device: taVNS sham
Chronic Pain and post Covid Syndrom - ActiveExperimentalThese volunteers will receive 30 minutes of taVNS on the afferent portion of the vagal nerve on the ears.
Receives: Device: taVNS - transauricular vagal nerve stimulation
Chronic Pain and post Covid Syndrom - ShamSham comparatorThese volunteers will receive 30 minutes of simulated taVNS on the afferent portion of the vagal nerve on the ears. For this, the equipment will be programmed to be on only for 1 minute.
Receives: Device: taVNS sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain

    It will be assessed through the Brief Pain Inventory (BPI), that assess place and pain intensity and its impact in life and by multidimensional pain assessment instruments to evaluate pain experience and self-efficacy

    Measured: 5 days

Secondary outcomes (4)
  1. Heart rate variability and blood preasure

    It will be done using a chest polar and a sphygmomanometer.

    Measured: 5 days

  2. Pressure pain threshold.

    Assessed through handgrip dynamometry.

    Measured: 5 days

  3. TMS-Evoked potential

    TMS-Evoked Potential is a measure derived from TMS stimulus on the brain which represent a brain reactivity to exogenous stimulus

    Measured: 5 days

  4. Disautonomy, fatigue and mental health

    Dysautonomia will be assessed through TMS-EEG. Fatigue will be assessed by physical, cognitive and psychosocial fatigue scales and fatigue perception questionnaire. Mental health will be assessed by anxiety, depression and sleep quality questionnaires. Quality of life will be assessed by a specific questionnaire.

    Measured: 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2024
  2. Study start21 Apr 2024
  3. Primary completion16 Dec 2024 (estimated)
  4. Study completion16 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Model description
First, we will test the savety and effects of neuromodulation using four different tecniques on autonomous system of healthy people. Then, we will test the effect of neuromodulation through, vagal stimulation, on pain, fatigue, mental healthy and disautonomy of people with primary chronic pain and/or post-COVID syndrom. For this, active and sham stimulations will be compared.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
55 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06689345
Sponsor's protocol ID
U1111-1293-2751
Status last verified
Sep 2024
First submitted
27 Sep 2024
Last updated
14 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing taVNS - transauricular vagal nerve stimulation, rPMS - repetitive peripheric magnetic stimulation and rTMS - repetitive transcranial magnetic stimulation in people with Post COVID Condition and Chronic Pain, run by Federal University of ABC at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain (time frame: 5 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in